Brief: Prostatype Genomics AB Says Sales In 2022 Are Estimated To Amount To Sek 700,000
Nov 7 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* SALES IN 2022 ARE ESTIMATED TO AMOUNT TO SEK 700,000
Source text for Eikon: ID:nWkrc8S5yH
Further company coverage: PROGEN.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue